We designed and validated the efficacy and specificity of two small interfering RNAs (siRNAs) against each of the mouse Uhrf1 and Uhrf2 using mouse P19 embryonic carcinoma cells (Figure 1d). Here, UHRF2 is linked to embryonal carcinoma.